Literature DB >> 23619914

A low-vision rehabilitation program for patients with mild cognitive deficits.

Heather E Whitson1, Diane Whitaker, Guy Potter, Eleanor McConnell, Fay Tripp, Linda L Sanders, Kelly W Muir, Harvey J Cohen, Scott W Cousins.   

Abstract

IMPORTANCE: We are unaware of any standardized protocols within low-vision rehabilitation (LVR) to address cognitive impairment.
OBJECTIVE: To design and pilot-test an LVR program for patients with macular disease and cognitive deficits.
DESIGN: The Memory or Reasoning Enhanced Low Vision Rehabilitation (MORE-LVR) program was created by a team representing optometry, occupational therapy, ophthalmology, neuropsychology, and geriatrics. This pilot study compares outcomes before and after participation in the MORE-LVR program.
SETTING: Eligible patients were recruited from an LVR clinic from October 1, 2010, through March 31, 2011. PARTICIPANTS: Twelve patients completed the intervention, and 11 companions attended at least 1 training session. INTERVENTION: Key components of the MORE-LVR intervention are as follows: (1) repetitive training with a therapist twice weekly during a 6-week period, (2) simplified training experience addressing no more than 3 individualized goals in a minimally distracting environment, and (3) involvement of an informal companion (friend or family member). MAIN OUTCOME MEASURES: Version 2000 National Eye Institute Vision Function Questionnaire-25; timed performance measures, Telephone Interview for Cognitive Status-modified(TICS-m), Logical Memory tests, satisfaction with activities of daily living, and goal attainment scales.
RESULTS: Twelve patients without dementia (mean age, 84.5 years; 75% female) who screened positive for cognitive deficits completed the MORE-LVR program. Participants demonstrated improved mean (SD) scores on the National Eye Institute's Visual Function Questionnaire-25 composite score (47.2 [16.3] to 54.8 [13.8], P = .01) and near-activities score (21.5 [14.0] to 41.0 [23.1], P = .02), timed performance measures (writing a grocery list [P = .03], filling in a crossword puzzle answer [P = .003]), a score indicating satisfaction with independence (P = .05), and logical memory (P = .02). All patients and companions reported progress toward at least 1 individualized goal; more than 70% reported progress toward all 3 goals. CONCLUSIONS AND RELEVANCE: This pilot study demonstrates feasibility of an LVR program for patients with macular disease and mild cognitive deficits. Participants demonstrated improvements in vision-related function and cognitive measures and expressed high satisfaction. Future work is needed to determine whether MORE-LVR is superior to usual outpatient LVR for persons with coexisting visual and cognitive impairments.

Entities:  

Mesh:

Year:  2013        PMID: 23619914      PMCID: PMC3710540          DOI: 10.1001/jamaophthalmol.2013.1700

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  49 in total

1.  A model of the prevalence and incidence of low vision and blindness among adults in the U.S.

Authors:  Robert W Massof
Journal:  Optom Vis Sci       Date:  2002-01       Impact factor: 1.973

2.  Prevalence of open-angle glaucoma among adults in the United States.

Authors:  David S Friedman; Roger C W Wolfs; Benita J O'Colmain; Barbara E Klein; Hugh R Taylor; Shelia West; M Cristina Leske; Paul Mitchell; Nathan Congdon; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

3.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

4.  Is early age-related maculopathy related to cognitive function? The Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; F Javier Nieto; Suzana A D Moraes; Thomas H Mosley; David J Couper; Barbara E K Klein; Lori L Boland; Larry D Hubbard; A Richey Sharrett
Journal:  Am J Ophthalmol       Date:  2002-12       Impact factor: 5.258

5.  Is age-related maculopathy associated with Alzheimer's Disease? The Rotterdam Study.

Authors:  C C Klaver; A Ott; A Hofman; J J Assink; M M Breteler; P T de Jong
Journal:  Am J Epidemiol       Date:  1999-11-01       Impact factor: 4.897

Review 6.  The role of health literacy in patient-physician communication.

Authors:  Mark V Williams; Terry Davis; Ruth M Parker; Barry D Weiss
Journal:  Fam Med       Date:  2002-05       Impact factor: 1.756

7.  Causes and prevalence of visual impairment among adults in the United States.

Authors:  Nathan Congdon; Benita O'Colmain; Caroline C W Klaver; Ronald Klein; Beatriz Muñoz; David S Friedman; John Kempen; Hugh R Taylor; Paul Mitchell
Journal:  Arch Ophthalmol       Date:  2004-04

8.  Prevalence of cataract and pseudophakia/aphakia among adults in the United States.

Authors:  Nathan Congdon; Johannes R Vingerling; Barbara E K Klein; Sheila West; David S Friedman; John Kempen; Benita O'Colmain; Suh-Yuh Wu; Hugh R Taylor
Journal:  Arch Ophthalmol       Date:  2004-04

9.  Measuring low-vision rehabilitation outcomes with the NEI VFQ-25.

Authors:  Joan A Stelmack; Thomas R Stelmack; Robert W Massof
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

10.  Memory deficit associated with worse functional trajectories in older adults in low-vision rehabilitation for macular disease.

Authors:  Heather E Whitson; Diane Whitaker; Linda L Sanders; Guy G Potter; Scott W Cousins; Deidra Ansah; Eleanor McConnell; Carl F Pieper; Lawrence Landerman; David C Steffens; Harvey J Cohen
Journal:  J Am Geriatr Soc       Date:  2012-11-05       Impact factor: 5.562

View more
  9 in total

1.  Insights into inpatients with poor vision: A high value proposition.

Authors:  Valerie G Press; Madeleine I Matthiesen; Alisha Ranadive; Seenu M Hariprasad; David O Meltzer; Vineet M Arora
Journal:  J Hosp Med       Date:  2015-03-09       Impact factor: 2.960

2.  Interventions Within the Scope of Occupational Therapy Practice to Improve Performance of Daily Activities for Older Adults With Low Vision: A Systematic Review.

Authors:  Chiung-Ju Liu; Megan C Chang
Journal:  Am J Occup Ther       Date:  2020 Jan/Feb

3.  Correlation between visual acuity and cognitive functions.

Authors:  Sivan M Elyashiv; Esther L Shabtai; Michael Belkin
Journal:  Br J Ophthalmol       Date:  2013-10-29       Impact factor: 4.638

4.  Self-reported dual sensory impairment, dementia, and functional limitations in Medicare beneficiaries.

Authors:  Lama Assi; Joshua R Ehrlich; Yunshu Zhou; Alison Huang; Judith Kasper; Frank R Lin; Michael M McKee; Nicholas S Reed; Bonnielin K Swenor; Jennifer A Deal
Journal:  J Am Geriatr Soc       Date:  2021-09-03       Impact factor: 7.538

5.  Cognitive Impairment among Veterans in Outpatient Vision Rehabilitation.

Authors:  Heather E Whitson; Sandra Woolson; Maren Olsen; Robert Massof; Stephanie M Ferguson; Kelly W Muir; John A Dziadul; Eleanor McConnell; Joan A Stelmack
Journal:  Optom Vis Sci       Date:  2020-06       Impact factor: 2.106

Review 6.  Sensorineural Organs Dysfunction and Cognitive Decline: A Review Article.

Authors:  Supakanya Wongrakpanich; Aisawan Petchlorlian; Andrew Rosenzweig
Journal:  Aging Dis       Date:  2016-12-01       Impact factor: 6.745

7.  Improving hearing and vision in dementia: protocol for a field trial of a new intervention.

Authors:  Jemma Regan; Piers Dawes; Annie Pye; Christopher J Armitage; Mark Hann; Ines Himmelsbach; David Reeves; Zoe Simkin; Fan Yang; Iracema Leroi
Journal:  BMJ Open       Date:  2017-11-28       Impact factor: 2.692

8.  Health coaching for glaucoma care: a pilot study using mixed methods.

Authors:  Anita Vin; Suzanne Schneider; Kelly W Muir; Jullia A Rosdahl
Journal:  Clin Ophthalmol       Date:  2015-10-22

9.  Recommendations for successful sensory screening in older adults with dementia in long-term care: a qualitative environmental scan of Canadian specialists.

Authors:  Walter Wittich; Fiona Höbler; Jonathan Jarry; Katherine S McGilton
Journal:  BMJ Open       Date:  2018-01-26       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.